Oct. 10 at 5:30 AM
$BINV Transgene and BioInvent - First Patient Treated in Part B of Phase I Trial Assessing the Novel Oncolytic Virus BT-001 in Combination With KEYTRUDA® (pembrolizumab)
https://www.stocktitan.net/news/BINV/transgene-and-bio-invent-first-patient-treated-in-part-b-of-phase-i-i0pfgkvgmowg.html